TD SYNNEX director sells 167 shares in plan

TD SYNNEX director Merline Saintil reported an open-market stock sale.

(Neutral)

(Negative)How Sentiment works

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

How Sentiment works How the balance works

Form Type

Rhea-AI Filing Summary

TD SYNNEX director Merline Saintil reported an open-market stock sale. On March 4, 2026, she sold 167 shares of TD SYNNEX common stock at an average price of $157.75 per share in an open-market transaction.

The sale was executed under a pre-set Rule 10b5-1 trading plan adopted on August 2, 2025, which automates trades according to predetermined instructions. Following this transaction, Saintil directly holds 6,995 TD SYNNEX common shares.

Insider Trade Summary

Net Seller: 167 shares

Net Sell 1 txn

Insider Saintil Merline

Role Director

Sold 167 shs ($26K)

Type	Security	Shares	Price	Value
Sale	Common Stock	167	$157.75	$26K

Holdings After Transaction: Common Stock — 6,995 shares (Direct)

Footnotes (1)

F1. These sales were effectuated pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 2, 2025.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did TD SYNNEX (SNX) director Merline Saintil report in this Form 4 filing?

Merline Saintil reported selling 167 TD SYNNEX common shares in an open-market transaction. The shares were sold at an average price of $157.75 per share, and the transaction was executed under a pre-arranged Rule 10b5-1 trading plan adopted in August 2025.

How many TD SYNNEX (SNX) shares did Merline Saintil sell and at what price?

Merline Saintil sold 167 shares of TD SYNNEX common stock at an average price of $157.75 per share. This was a non-derivative, open-market sale reported in a Form 4, reflecting a relatively small portion of her overall direct holdings in the company.

How many TD SYNNEX (SNX) shares does Merline Saintil hold after the reported sale?

After the reported transaction, Merline Saintil directly holds 6,995 shares of TD SYNNEX common stock. This figure reflects her remaining direct ownership following the sale of 167 shares disclosed in the Form 4 insider trading report.

Was Merline Saintil’s TD SYNNEX (SNX) stock sale under a Rule 10b5-1 plan?

Yes. The filing notes that the sales were effectuated under a Rule 10b5-1 trading plan adopted by Merline Saintil on August 2, 2025. Such plans allow insiders to sell shares according to pre-set instructions, helping separate trading decisions from later, non-public information.

What type of transaction did TD SYNNEX (SNX) director Merline Saintil report?

She reported a non-derivative open-market sale of common stock, coded as “S” in the Form 4. This indicates a sale in the open market or a private transaction, rather than an option exercise, grant, or other derivative-related activity involving TD SYNNEX securities.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

Accepted by SEC EDGAR 03/05/2026 - 05:10 PM EST

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Saintil Merline

(Last)

(First)

(Middle)

44201 NOBEL DRIVE

(Street)

FREMONT

94538

(City)

(State)

(Zip)

2. Issuer Name and Ticker or Trading Symbol
TD SYNNEX CORP [ SNX ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	10% Owner
	Officer (give title below)	Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
03/04/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common Stock	03/04/2026		S⁽¹⁾		167	D	$157.75	6,995	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)

Explanation of Responses:

1. These sales were effectuated pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 2, 2025.

Remarks:

	/s/ Cheryl Grant, attorney-in-fact	03/05/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

Source: View Original Filing on SEC EDGAR